Saint John Regional Hospital
Saint John, New Brunswick, E2L4L2, Canada
NCT Number: NCT01438515
MRSA decolonization may reduce the risk of subsequent MRSA infection and further transmission. A recent randomized controlled trial demonstrated that systemic decolonization may be safe and effective among hospitalized patients when compared to no treatment. As a large number of the investigators patients require re-admission and further transmission may take place in the community, the investigators are comparing the standard decolonization protocol for MRSA eradication to the systemic decolonization protocol among an ambulatory population.
Standard decolonization protocols, which use only topical agents, are limited in efficacy. The method of systemic decolonization to be studied here appears to have greater efficacy than the standard approach using only topical agents. However, concerns have been raised that the increased use of systemic antibiotics may lead to increased levels of drug resistance adverse effects, without sustained decolonization. This study seeks to provide further data to help answer these questions and provide guidance for further policy development and implementation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Saint John, New Brunswick, E2L4L2, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
600mg po once daily x 7 days
100mg po twice daily x 7 days
~ 1cm applied to the anterior nares twice daily for 7 days
Daily full body wash (including hair) for 7 days
Time frame: 12 months
To compare standard versus systemic decolonization for their ability to sustain MRSA decolonization up to one year post-decolonization.
Time frame: 12 months
Study isolates will be evaluated with regards to mupirocin, rifampin and tetracycline resistance patterns, where individuals remain colonized, or re-colonize subsequent to implementation of the decolonization protocol.
Horizon Health Network
Other
Randomized Controlled Trial of Chlorhexidine Gluconate, Intranasal Mupirocin, Rifampin and Doxycycline Versus Chlorhexidine Gluconate and Intranasal Mupirocin Alone for the Eradication of Methicillin-resistant Staphylococcus Aureus Among an Ambulatory Patient Population
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04171817
Bacterial Infections, Bacterial Infections and Mycoses
Baltimore, Maryland, United States
View Trial DetailsNCT03637400
Cellulitis, Connective Tissue Diseases
Sylmar, California, United States
View Trial DetailsNCT01209234
Methicillin-Resistant Staphylococcus Aureus
Aliso Viejo, California, United States
View Trial DetailsNCT05529173
Infections, Methicillin-Resistant Staphylococcus Aureus
Newark, New Jersey, United States
View Trial Details